Question 1 - What will be the existing C suites renumeration under thoma bravo? (based upon their previous takeover practices)
Question 2 - What personal offers have the board been given to support this deal?
Question 3 - What has been the response from institutional investors who paid plus $2.70 per share a year or so ago?
This takeover is spectacularly undervalued by most measures. I don't understand how the company can and have done so many hard yards over so many years only to hand the company over at a discount, something stinks...
